Aubagio (teriflunomide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Aubagio (teriflunomide), covering 2025-04-13 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia [Phase 2]